Sunscreen: Persistence of Sun Protection Factor and the Influence on Vitamin D
NCT ID: NCT00711256
Last Updated: 2008-07-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
80 participants
INTERVENTIONAL
2008-07-31
2008-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
FACTORIAL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
No sunscreen applied
UVB light
duration 4 times 1 minute radiation on the trunk.
2
Sunscreen applied 0.5 mg/cm2
UVB light
duration 4 times 1 minute radiation on the trunk.
3
Sunscreen applied 1mg/cm2
UVB light
duration 4 times 1 minute radiation on the trunk.
4
Sunscreen applied 2mg/cm2
sunscreen MATAS sunlotion SPF 8
UVB light
duration 4 times 1 minute radiation on the trunk.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
sunscreen MATAS sunlotion SPF 8
UVB light
duration 4 times 1 minute radiation on the trunk.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* \> 18 years.
* Skin type I, II, and III.
Exclusion Criteria
* Medicin use.
* Skin or other diseases.
* The participants must not have been in solarium or gotten sun on their trunks in the 3 months before the study start and during the study.
* Skin types IV and above.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bispebjerg Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bispebjerg Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bispebjerg Hospital
Copenhagen, KBH NV, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Hans Christian Wulf, Dr.med
Role: CONTACT
Phone: +45 3135 3155
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
HC Wulf, Dr.med
Role: primary
Ditte Beyer, stud.med
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Beyer DM, Faurschou A, Philipsen PA, Haedersdal M, Wulf HC. Sun protection factor persistence on human skin during a day without physical activity or ultraviolet exposure. Photodermatol Photoimmunol Photomed. 2010 Feb;26(1):22-7. doi: 10.1111/j.1600-0781.2009.00479.x.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H-B-2007-120
Identifier Type: -
Identifier Source: org_study_id